2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T5c69,

Summary Table

Category	Details
Risk Factors	Age under 5 years (peak diagnosis at 18 months), family history of retinoblastoma, germline RB1 mutation, sibling with hereditary retinoblastoma
Etiology	Biallelic inactivation of the RB1 tumor suppressor gene on chromosome 13q14 (Knudson two-hit hypothesis)
Patient Presentation	Toddler brought in because parents noticed a "white spot" or "cat's eye glow" in photographs; crossed eye; occasionally a red, painful eye or vision loss
Classic Physical Exam	Leukocoria (white pupillary reflex replacing the normal red reflex), strabismus, sometimes proptosis, hyphema, or secondary glaucoma in advanced disease
Key Diagnostic Results	Dilated fundoscopy under anesthesia shows a creamy white retinal mass; B-scan ocular ultrasound demonstrates an intraocular mass with intratumoral calcifications; MRI of the orbits and brain assesses optic nerve and extraocular extension
Management	Depends on tumor group and laterality. Options include systemic, intra-arterial, or intravitreal chemotherapy, focal therapy (laser photocoagulation, cryotherapy, plaque brachytherapy), and enucleation for advanced unilateral disease. Lifelong surveillance for second cancers in hereditary cases.
Keywords	"Leukocoria," "white pupillary reflex," "absent red reflex," "cat's eye reflex," "RB1 gene," "chromosome 13q14," "calcifications on B-scan," "Knudson two-hit," "bilateral in hereditary form," "secondary osteosarcoma"

1. Pathophysiology

Retinoblastoma arises from immature retinal cells, most likely cone precursors, when both copies of the RB1 tumor suppressor gene are inactivated. RB1 normally encodes the pRB protein, which binds and sequesters the E2F transcription factor, holding the cell at the G1/S checkpoint. When pRB is lost, E2F is freed, the checkpoint collapses, and the precursor cell proliferates uncontrollably to form a retinal tumor.

The Knudson two-hit hypothesis is central to how this disease is tested. In the hereditary form (around 40% of cases), the child inherits one defective RB1 allele in every cell of the body. Only a single somatic "second hit" is then needed for tumor formation, which is why hereditary cases tend to be bilateral, multifocal, and present earlier (often under 12 months). In the sporadic form (around 60%), both hits must occur in the same retinal cell after birth, so the tumor is typically unilateral, unifocal, and presents later (around 24 months).

As the tumor grows, it disrupts the normal retina and replaces the choroidal pigment behind the pupil with a chalky white mass. Because light entering the eye is reflected off this pale tumor instead of the vascular retina, the red reflex is replaced by a white pupillary reflex (leukocoria). If the tumor distorts central vision, the affected eye loses fixation and drifts, producing strabismus, which is the second most common presenting sign. Advanced tumors can seed the vitreous, invade the optic nerve (a route to the central nervous system), or extend through the sclera into the orbit.

A clinically important point is that children with the germline RB1 mutation carry a lifelong risk of second primary malignancies, most notably osteosarcoma, soft tissue sarcomas, and melanoma, because every cell already harbors one inactivated allele.

2. Classification and Clinical Manifestation

The most widely tested staging scheme for intraocular disease is the International Classification of Retinoblastoma (ICRB), which guides eye salvage decisions.

Group	Tumor Description	Prognosis for Eye Salvage
A	Small tumors (3 mm or less), confined to retina, away from fovea and optic disc	Excellent
B	Larger tumors confined to retina, or near fovea/disc, no seeding	Very good
C	Localized vitreous or subretinal seeding near the tumor	Good with aggressive therapy
D	Diffuse vitreous or subretinal seeding, retinal detachment	Guarded
E	Massive tumor filling the globe, neovascular glaucoma, hemorrhage, or invasion of anterior segment, optic nerve, or choroid	Enucleation usually required

For extraocular spread, the International Retinoblastoma Staging System (IRSS) is used (Stage 0 through IV), with Stage IV indicating distant metastasis.

Clinical manifestations by pattern:

Pattern	Typical Vignette Clue
Leukocoria	One pupil glowing white instead of red
Strabismus	Eye drifts inward or outward in an otherwise healthy toddler
Red, painful eye	Mimics uveitis or orbital cellulitis; suggests advanced disease
Secondary glaucoma	Eye pain, tearing, corneal clouding, buphthalmos
Proptosis	Late finding indicating extraocular extension
Trilateral retinoblastoma	Bilateral retinoblastoma plus a midline intracranial primitive neuroectodermal tumor (often pineal)

3. Diagnostic Workup

Test	Role	Key Finding
Red reflex test (penlight or ophthalmoscope)	First screening tool in any well-child visit	Asymmetric or absent red reflex; leukocoria
Dilated indirect ophthalmoscopy under general anesthesia	Best initial diagnostic test	Creamy white, vascularized retinal mass with possible vitreous seeding
B-scan ocular ultrasound	Confirms intraocular mass and characterizes it	Intraocular mass with intratumoral calcifications
MRI of orbits and brain (with contrast)	Most accurate test for staging; also screens for trilateral disease	Optic nerve invasion, extraocular extension, pineal mass
CT scan	Generally avoided	Sensitive for calcification but exposes a child with a tumor predisposition syndrome to ionizing radiation
Genetic testing for RB1 mutation	Risk stratification for the patient and family	Germline mutation confirms hereditary form
Lumbar puncture and bone marrow biopsy	Reserved for suspected metastatic disease	Tumor cells in cerebrospinal fluid or marrow

The workup begins with the simplest tool available to any clinician, which is the red reflex test. An abnormal or asymmetric red reflex in a child should never be dismissed as a camera artifact. Once leukocoria or strabismus raises suspicion, the child is referred urgently to pediatric ophthalmology for an examination under anesthesia (EUA) with dilated indirect ophthalmoscopy. This is the best initial diagnostic test because it allows full visualization of the retina, mapping of all tumor foci, and assessment of vitreous seeding.

B-scan ultrasound is performed at the same time. The presence of an intraocular mass with calcifications in a child under 3 years old is essentially diagnostic of retinoblastoma, and this is the imaging finding most often tested. MRI of the orbits and brain with contrast is then obtained to evaluate optic nerve and extraocular involvement and to screen for trilateral retinoblastoma, the association of bilateral disease with a midline intracranial neuroblastic tumor. CT is generally avoided because radiation can induce second tumors in children with germline RB1 mutations.

A test the exam loves to penalize students for ordering is biopsy. Transscleral biopsy is contraindicated because it can seed tumor cells into the orbit and convert a curable intraocular disease into a metastatic one. Diagnosis is therefore clinical and radiologic.

Once the diagnosis is established, RB1 genetic testing is offered to the patient and first-degree relatives, and bilateral or multifocal disease is treated as hereditary even if no mutation is identified.

4. Management and Treatment

Approach	Indication	Notes
Focal therapy (laser photocoagulation, cryotherapy, transpupillary thermotherapy, plaque brachytherapy)	Small tumors (Group A and selected Group B)	Eye-sparing; often combined with chemotherapy
Systemic chemotherapy (chemoreduction)	Bilateral disease, hereditary disease, or larger intraocular tumors (Groups B to D)	Standard regimen is vincristine, etoposide, and carboplatin (VEC), typically 6 cycles
Intra-arterial chemotherapy (ophthalmic artery infusion of melphalan)	Advanced unilateral or bilateral intraocular disease (Groups C and D)	Delivers high local dose, spares systemic toxicity
Intravitreal chemotherapy (melphalan or topotecan)	Persistent or recurrent vitreous seeding	Given by direct injection into the vitreous
Enucleation	Group E, neovascular glaucoma, no useful vision potential, or extensive disease	Followed by histopathology to identify high-risk features
Adjuvant systemic chemotherapy after enucleation	High-risk pathology: post-laminar optic nerve invasion, choroidal invasion, or anterior segment involvement	Prevents metastatic spread
External beam radiotherapy	Reserved for refractory disease	Limited because of risk of second malignancy and orbital growth disturbance
Long-term surveillance	All hereditary cases	Lifelong screening for osteosarcoma, sarcomas, and melanoma

Management is individualized according to laterality, tumor group, vision potential, and germline status, and is always coordinated by an experienced pediatric oncology and ocular oncology team.

For early intraocular disease (Groups A and B), vision-preserving focal therapy is the cornerstone. Laser photocoagulation and cryotherapy are used for small posterior and peripheral tumors, respectively, often after a few cycles of systemic chemoreduction with VEC (vincristine, etoposide, and carboplatin) to shrink the tumor first.

For advanced intraocular disease (Groups C and D), the modern standard in many centers is intra-arterial chemotherapy, in which melphalan is infused directly into the ophthalmic artery, sometimes combined with topotecan or carboplatin. Intravitreal melphalan or topotecan is added when vitreous seeds are present, since systemic agents penetrate the vitreous poorly.

For Group E disease, an eye filled with tumor, neovascular glaucoma, hyphema, or no salvageable vision, primary enucleation is the treatment of choice. The surgeon harvests as long an optic nerve stump as possible (around 10 to 15 mm) so the pathologist can assess invasion. If pathology reveals post-laminar optic nerve invasion, massive choroidal invasion, or anterior chamber involvement, adjuvant systemic chemotherapy is given to reduce metastatic risk.

The "next best step" logic that examinations reward is straightforward. A toddler with leukocoria on photographs goes for urgent ophthalmology referral and EUA, not biopsy. A child with confirmed retinoblastoma needs MRI of the brain and orbits before any therapeutic decision, both for staging and to screen for trilateral disease. A child with a Group E eye and no vision potential should proceed to enucleation rather than indefinite chemotherapy attempts.

Contraindications and cautions: external beam radiotherapy is avoided whenever possible in children with germline RB1 mutations because it dramatically increases the risk of radiation-induced sarcomas in the field. CT imaging is similarly minimized for the same reason. Live vaccines should be deferred during active chemotherapy.

Long-term management centers on lifelong surveillance. Survivors of hereditary retinoblastoma have a substantial cumulative risk of second primary malignancies, most classically osteosarcoma of the femur in adolescence, as well as soft tissue sarcomas and cutaneous melanoma. Genetic counseling is offered to the family, and siblings undergo serial fundoscopy in infancy.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Is Similar	Key Discriminator
Congenital cataract	Both cause leukocoria in an infant	Cataract gives a uniform white opacity at the lens level, no retinal mass on ultrasound, no calcifications
Persistent fetal vasculature (persistent hyperplastic primary vitreous)	Leukocoria, often unilateral, in a young infant	Affected eye is typically microphthalmic; ultrasound shows a stalk from disc to lens, no calcifications
Coats disease	Leukocoria, retinal detachment, white reflex	Older child (school-aged), almost always unilateral, male, ultrasound shows exudative retinal detachment without calcifications
Toxocariasis (ocular larva migrans)	Leukocoria with a white retinal lesion	History of contact with puppies or dirt ingestion, eosinophilia, granuloma without calcifications, positive serology
Retinopathy of prematurity	Leukocoria from retinal detachment	History of prematurity, low birth weight, oxygen exposure, bilateral, no calcified mass
Astrocytic hamartoma (tuberous sclerosis)	White retinal lesion that may calcify	Other features of tuberous sclerosis: ash-leaf macules, seizures, cortical tubers
Endophthalmitis or uveitis	Red painful eye in a child	Inflammatory cells, hypopyon, infectious history, no calcified mass
Retinal detachment from other causes	White reflex from detached retina	Identifiable cause (trauma, prematurity), no discrete calcified intraretinal mass

6. Traps and High-Yield Pearls

The classic trap is the parent who brings a photograph showing one eye glowing white while the other glows red, and the clinician reassures them that it is a camera flash artifact. Asymmetric or absent red reflex in a child is retinoblastoma until proven otherwise, and the correct next step is urgent referral for examination under anesthesia, not observation. A second common mistake is choosing biopsy to confirm the diagnosis. Transscleral biopsy seeds tumor and is contraindicated; the diagnosis is made by fundoscopy plus B-scan ultrasound showing a calcified intraocular mass, with MRI for staging. A third pitfall is forgetting that bilateral or multifocal disease is hereditary by definition, even when family history is negative, which means lifelong surveillance for second malignancies (especially osteosarcoma) and genetic counseling for the family. A fourth pitfall is reflexively ordering a CT scan for calcifications; in a child with a possible germline RB1 mutation, this needlessly raises the lifetime risk of radiation-induced tumors, so MRI is preferred. Finally, do not overlook trilateral retinoblastoma, the association of bilateral retinoblastoma with a midline intracranial neuroblastic tumor, usually pineal, which is why every child with bilateral disease needs brain MRI at diagnosis.

The core competency being tested is recognizing leukocoria as a red flag in a young child, ordering the right sequence of noninvasive investigations (red reflex, then EUA with B-scan, then MRI), avoiding harmful steps (biopsy, CT, external beam radiation when avoidable), and understanding the genetic logic that links hereditary retinoblastoma to bilateral disease, early onset, and lifelong cancer risk.

1e:["$","$L2d",null,{"article":{"id":"1c15294f-c7c2-44cb-b034-441f83de3250","title":"Retinoblastoma","content":"$2e","category":"Oftalmologi","created_at":"2026-05-01T13:45:01.127522+00:00","status":"published","subcategory":null},"questionCount":2,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]